Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leishmaniasis, Visceral”

Showing 20 of 0 results

Not applicableStudy completedNCT06983665
What this trial is testing

Human Bioequivalence Study of Liposomal Amphotericin B for Injection

Who this might be right for
Invasive Fungal InfectionsNeutropenic FeverVisceral Leishmaniasis
Sichuan Huiyu Pharmaceutical Co., Ltd 58
Large-scale testing (Phase 3)Study completedNCT00255567
What this trial is testing

Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 1,142
Large-scale testing (Phase 3)Study completedNCT00216346
What this trial is testing

Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
PATH 667
Post-approval studies (Phase 4)Study completedNCT01032187
What this trial is testing

Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children

Who this might be right for
Visceral Leishmaniasis
University of Brasilia 101
Not applicableLooking for participantsNCT05602610
What this trial is testing

Clinical Prognostic Score to Predict Relapse in VL

Who this might be right for
Visceral Leishmaniasis
Institute of Tropical Medicine, Belgium 741
Testing effectiveness (Phase 2)Ended earlyNCT00378495
What this trial is testing

Miltefosine for Brazilian Visceral Leishmaniasis

Who this might be right for
Kala Azar
AB Foundation 80
Not applicableLooking for participantsNCT07487350
What this trial is testing

Recurrent Visceral Leishmaniasis in HIV Co-Infection

Who this might be right for
HivVisceral Leishmaniasis
Institute of Tropical Medicine, Belgium 20
Testing effectiveness (Phase 2)Study completedNCT00381394
What this trial is testing

A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis.

Who this might be right for
Leishmaniasis, Visceral
GlaxoSmithKline 61
Not applicableStudy completedNCT00001169
What this trial is testing

Clinical Investigation of Infections Due to Leishmanial Parasites

Who this might be right for
LeishmaniasisLeishmaniasis, Visceral
National Institute of Allergy and Infectious Diseases (NIAID) 250
Large-scale testing (Phase 3)Study completedNCT00696969
What this trial is testing

Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 634
Not applicableStudy completedNCT01328457
What this trial is testing

An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh

Who this might be right for
Visceral Leishmaniasis
PATH 120
Testing effectiveness (Phase 2)WithdrawnNCT01437020
What this trial is testing

SCH708980 With and Without AmBisome for Visceral Leishmaniasis

Who this might be right for
LeishmaniasisEffects of Immunotherapy
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT07809919
What this trial is testing

A First-in-human, Safety, Tolerability, and Pharmacokinetics Study of LXE408 in Healthy Subjects

Who this might be right for
Visceral LeishmaniasisChagas Disease
Novartis Pharmaceuticals 88
Not applicableUnknownNCT01138956
What this trial is testing

Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine

Who this might be right for
Visceral LeishmaniasisImmune ResponseTreatment
Hospital Universitário Professor Edgard Santos 40
Not applicableStudy completedNCT06977490
What this trial is testing

Human Bioequivalence Study of Amphotericin B Liposome for Injection

Who this might be right for
Invasive Fungal InfectionsNeutropenic FeverVisceral Leishmaniasis
Sichuan Huiyu Pharmaceutical Co., Ltd 42
Not applicableStudy completedNCT03303898
What this trial is testing

ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE -

Who this might be right for
Leishmaniasis, Cutaneous
Centre Hospitalier Universitaire de Nice 30
Post-approval studies (Phase 4)Ended earlyNCT01310738
What this trial is testing

Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil

Who this might be right for
Visceral Leishmaniasis
University of Brasilia 378
Testing effectiveness (Phase 2)Ended earlyNCT00832208
What this trial is testing

Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 124
Large-scale testing (Phase 3)Study completedNCT01360762
What this trial is testing

Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study

Who this might be right for
Visceral LeishmaniosisHIV-infection/Aids
Institute of Tropical Medicine, Belgium 74
Testing effectiveness (Phase 2)Study completedNCT02431143
What this trial is testing

Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation